2021 ASCO Virtual Annual Meeting*

Download All
June 4-8, 2021; Online at https://conferences.asco.org/am
Expert faculty review and share their insights and perspectives on key findings in gastrointestinal cancers presented at the 2021 ASCO Annual Meeting.
Manish A. Shah, MD

Gastrointestinal Cancers

Slidesets KEYNOTE-177 Final Analysis: First-line Pembrolizumab vs Chemotherapy in MSI-H/dMMR Metastatic CRC
Slidesets CheckMate 649: Additional Analysis From the Phase III Trial of First-line Nivolumab + CT vs CT for Advanced Gastroesophageal Cancers
Slidesets CheckMate 577 Update: Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer After Neoadjuvant Chemotherapy
Slidesets KEYNOTE-811: First-line Pembrolizumab + Trastuzumab and Chemotherapy in HER2+ Metastatic Gastric or Gastroesophageal Junction Cancer
Slidesets CheckMate 648: Nivolumab + Ipilimumab or Chemotherapy vs Chemotherapy Alone for First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma

Review expert perspectives on the most clinically relevant data on colorectal and gastroesophageal cancers presented at the 2021 ASCO Annual Meeting.

Manish A. Shah, MD Physicians: maximum of 0.75 AMA PRA Category 1 Credits™ Released: July 27, 2021 Expired: No longer available for credit
Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Merck Sharp & Dohme Corp.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings